Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
In the context of Sub-saharian Africa, this trial evaluate one of the most simple treatment
available for HIV-1 infected patients. The combination proposed is a triple antiretroviral
therapy with only one intake of 3 pills per day. This combination has already been studied in
the North countries.
Here in Senegal, the efficacy and the compliance to treatment will be evaluated after 24, 48
and 96 weeks of treatment.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators:
Gilead Sciences Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba